Future Market Insights2h
Global Direct Oral Anticoagulants Market Projected to Reach USD 71.78 Billion by 2032, Driven by FDA Approvals and Rising Thrombosis Cases
One of the primary factors fueling the growth of the DOACs market is the rapid uptake and expected utilization within the ...
Yahoo Finance2d
GoodRx Holdings, Inc. (GDRX)
October 10, 2024--GoodRx Holdings, Inc. (Nasdaq: GDRX ... GoodRx announced a new partnership with Boehringer Ingelheim to provide discounts for a biosimilar to rheumatoid arthritis drug Humira ...
PharmiWeb23h
Global Progressive Fibrosing Interstitial Lung Disease Market Projected to Reach USD 8654.1 Million by 2033 at a 6.2% of CAGR
The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is ...
JD Supra19h
Classified (Bi-)Monthly: A Roundup of Class Action Decisions From Federal Appellate Courts July and August 2024
The Roundup covers notable class action decisions from federal appellate courts and notable Supreme Court class action cert petitions.
PharmiWeb1d
Thrombocytopenia Treatment Market Expected to Reach USD 10 Billion by 2033, Growing at a CAGR of 5.2%
Global Thrombocytopenia Treatment IndustryThe global Thrombocytopenia Treatment Market is projected to experience significant ...
C4 Therapeutics, Inc.: C4 Therapeutics Appoints Paige Mahaney, Ph.D., as Chief Scientific Officer and Announces Retirement of Stewart Fisher, Ph.D.
Mahaney Brings More Than 25 Years of Pharmaceutical and Biotech Experience Overseeing Drug Discovery and Expansion of Leading Discovery and Clinical Portfolios Fisher Will Serve as Senior Scientific ...
Medscape3d
Nemolizumab Reassures in Long-Term Follow-Up Atopic Dermatitis Study
An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...
C4 Therapeutics Appoints Paige Mahaney, Ph.D., as Chief Scientific Officer and Announces Retirement of Stewart Fisher, Ph.D.
Paige Mahaney, Ph.D. Chief Scientific Officer Mahaney Brings More Than 25 Years of Pharmaceutical and Biotech Experience ...
Future Market Insights21h
Global Hidradenitis Suppurativa Treatment Market Projected to Reach USD 1,240.9 Million by 2033, With a CAGR of 4.97%
The major players in the market are Inflarx, Novartis Pharmaceuticals ... Boehringer Ingelheim, Eli Lilly, Moonlake ...
American Association of Individual Investors2d
Which Is a Better Investment, Eli Lilly And Co or Pfizer Inc. Stock?
Sifting through countless of stocks in the Pharmaceuticals industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...